Top Markets
#1 0G 0G +27.23%
#2 SAFEcoin SAFEcoin +22.07%
#3 Cysic Cysic +21.21%
#4 Axelar Axelar +20.27%
#5 Zora Zora +19.14%
#6 Full Moon Full Moon +18.76%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.39%
#8 AI XOVIA AI XOVIA +16.31%
#9 StonkBroker StonkBroker +15.74%
#10 VVS Finance VVS Finance +14.74%
Coin of the day
0G 0G
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Classement en actions #12973
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Prix de l'action
$0.66137861
Capitalisation boursière
$531.70M
Changement (1 jour)
-2.45%
Changement (1 an)
-42.12%
Pays
CN
Échange Ocumension Therapeutics (1477)

Catégorie

Healthcare
Ratio P/B pour Ocumension Therapeutics (1477)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Ocumension Therapeutics, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Ocumension Therapeutics de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH